trending Market Intelligence /marketintelligence/en/news-insights/trending/es0zIbOH5urWG63uAo0Nfw2 content esgSubNav
In This List

AMS Life Science fiscal Q3 profit falls YOY

Podcast

Street Talk | Episode 94: Recessionary fears in '22 overblown, Fed could overtighten

Blog

Optimism abounds in Indian online video industry

Blog

2022 broadband forecast shifts to market share battle with intense competition

Blog

Expand Your Perspective: Innovation


AMS Life Science fiscal Q3 profit falls YOY

AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal third quarter ended May 31 amounted to ¥8.23 per share, a decrease of 32.3% from ¥12.16 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥100.0 million, a decrease of 32.1% from ¥147.3 million in the year-earlier period.

The normalized profit margin fell to 2.9% from 4.2% in the year-earlier period.

Total revenue declined year over year to ¥3.46 billion from ¥3.50 billion, and total operating expenses grew from the prior-year period to ¥3.29 billion from ¥3.25 billion.

Reported net income declined 46.5% year over year to ¥97.2 million, or ¥8.00 per share, from ¥181.7 million, or ¥15.00 per share.

As of July 15, US$1 was equivalent to ¥105.85.